PepGen Financials

PEPG Stock  USD 4.41  0.09  2.08%   
Based on the analysis of PepGen's profitability, liquidity, and operating efficiency, PepGen is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December. At this time, PepGen's Property Plant And Equipment Net is most likely to increase significantly in the upcoming years. The PepGen's current Accounts Payable is estimated to increase to about 1.4 M, while Total Current Liabilities is projected to decrease to roughly 10.5 M. Key indicators impacting PepGen's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.03220.0277
Fairly Up
Pretty Stable
Current Ratio11.836.4274
Way Up
Pretty Stable
The essential information of the day-to-day investment outlook for PepGen includes many different criteria found on its balance sheet. An individual investor should monitor PepGen's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in PepGen.

Net Income

(74.69 Million)

  
Understanding current and past PepGen Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of PepGen's financial statements are interrelated, with each one affecting the others. For example, an increase in PepGen's assets may result in an increase in income on the income statement.

PepGen Stock Summary

PepGen competes with Pmv Pharmaceuticals, Eliem Therapeutics, MediciNova, Pharvaris, and Molecular Partners. PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts. Pepgen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 36 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS7133171055
CUSIP713317105
LocationMassachusetts; U.S.A
Business Address321 Harrison Avenue,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitepepgen.com
Phone781 797 0979
CurrencyUSD - US Dollar

PepGen Key Financial Ratios

PepGen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining PepGen's current stock value. Our valuation model uses many indicators to compare PepGen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PepGen competition to find correlations between indicators driving PepGen's intrinsic value. More Info.
PepGen is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, PepGen's Return On Equity is most likely to slightly decrease in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value PepGen by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

PepGen Systematic Risk

PepGen's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. PepGen volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on PepGen correlated with the market. If Beta is less than 0 PepGen generally moves in the opposite direction as compared to the market. If PepGen Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one PepGen is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of PepGen is generally in the same direction as the market. If Beta > 1 PepGen moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in PepGen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various PepGen's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of PepGen growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.16)

At this time, PepGen's Price Earnings To Growth Ratio is most likely to increase slightly in the upcoming years.

PepGen November 25, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of PepGen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of PepGen. We use our internally-developed statistical techniques to arrive at the intrinsic value of PepGen based on widely used predictive technical indicators. In general, we focus on analyzing PepGen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build PepGen's daily price indicators and compare them against related drivers.

Complementary Tools for PepGen Stock analysis

When running PepGen's price analysis, check to measure PepGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PepGen is operating at the current time. Most of PepGen's value examination focuses on studying past and present price action to predict the probability of PepGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PepGen's price. Additionally, you may evaluate how the addition of PepGen to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Global Correlations
Find global opportunities by holding instruments from different markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities